Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 64 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 8765751

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  2. US 8765797

    TG2 inhibitors and uses thereof

    The Board of Regents of the University of Texas System · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  3. US 8765802

    Kinase inhibitors, compositions thereof, and methods of use therewith

    United States of America as represented by the Department of Health and Human Resources NIH · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  4. US 8765817

    Selective inhibitors of EG5 motors and methods of use

    Arrowhead Center, Inc. · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  5. US 8759332

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  6. US 8759327

    Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  7. US 8759392

    Amides as inhibitors of human secreted phospholipase A2

    The Regents of the University of California · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  8. US 8759389

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  9. US 8754050

    Macrocyclic compounds useful as inhibitors of histone deacetylases

    The Regents of the University of Colorado · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted
  10. US 8754080

    Pyrimidine substituted purine compounds as kinase (S) inhibitors

    VERASTEM, INC. · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted
  11. US 8754034

    Structure-based design of peptide inhibitors of amyloid fibrillation

    The Regents of the University of California · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted
  12. US 8748601

    Selective serine/threonine kinase inhibitors

    The Regents of the University of California · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted
  13. US 8748607

    Imidazopyrizine syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted
  14. US 8742121

    Process for the preparation of small molecule inhibitors of MDM2 and intermediates used therein

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  15. US 8741912

    Deazapurines useful as inhibitors of Janus kinases

    Vertex Pharmaceuticals Incorporated · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  16. US 8741937

    Gamma glutamyl transpeptidase inhibitors and methods of use

    The Board of Regents of the University of Oklahoma · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  17. US 8741898

    Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  18. US 8735418

    Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases

    Rigel Pharmaceuticals, Inc. · Granted May 27, 2014 · Expires May 22, 2034

    granted
  19. US 8735593

    Aminopyridines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted May 27, 2014 · Expires May 22, 2034

    granted
  20. US 8729119

    Serotonin reuptake inhibitors

    Theravance, Inc. · Granted May 20, 2014 · Expires May 15, 2034

    granted
  21. US 8722889

    Azaindoles useful as inhibitors of JAK and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted May 13, 2014 · Expires May 8, 2034

    granted
  22. US 8722708

    Substituted isoindolines as aspartyl protease inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted May 13, 2014 · Expires May 8, 2034

    granted
  23. US 8722895

    Prolyl hydroxylase inhibitors and method of use

    Akebia Therapeutics, Inc. · Granted May 13, 2014 · Expires May 8, 2034

    granted
  24. US 8716315

    Analogs of thalidomide as potential angiogenesis inhibitors

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 6, 2014 · Expires May 1, 2034

    granted